Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
EyePoint, Inc.
Report date March 30, 2024 · Filed April 02, 2024
Section 16 reporting ended · disclosed 2024-04-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 67,080 |
Ending reported balance
After 2024-03-30 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2024-03-30 · Exercise / conversion · Acquired 5,834 · Balance 48,056 Row 2 · 2024-03-30 · Exercise / conversion · Acquired 30,570 · Balance 78,626 Row 3 · 2024-03-30 · Exercise / conversion · Acquired 14,000 · Balance 92,626 Row 4 · 2024-03-30 · Tax withholding · Disposed 15,493 · Balance 77,133 F1: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Row 5 · 2024-03-30 · Tax withholding · Disposed 2,957 · Balance 74,176 F1: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Row 6 · 2024-03-30 · Tax withholding · Disposed 7,096 · Balance 67,080 F1: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2024-03-30 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2024-03-30 · Exercise / conversion · Disposed 30,570 · Balance 0 F2: The restricted stock units will vest in three ratable annual installments beginning January 6, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2024-03-30 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2024-03-30 · Exercise / conversion · Disposed 5,834 · Balance 0 F3: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2024-03-30 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2024-03-30 · Exercise / conversion · Disposed 14,000 · Balance 0 F4: The restricted stock units will vest in three ratable annual installments beginning January 5, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units
F2: The restricted stock units will vest in three ratable annual installments beginning January 6, 2024.
F3: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023.
F4: The restricted stock units will vest in three ratable annual installments beginning January 5, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 13, 2023 Filed Dec 15, 2023 22:14 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,458 | $0.00 Strike: $10.13 | $0.00 |
DisclosureSEC source: 0001562180-23-008415 · primarydocument.xml · derivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,917 Underlying: Common Stock · 1,458 shares Expires 2032-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option to purchase vests and becomes exercisable as follows: 25% at February 9th, 2023 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:14 UTC | EyePoint, Inc. EYPT · Entity 5702 | SaleCommon Stock | 1,458 | $20.00 | $29,160.00 |
DisclosureSEC source: 0001562180-23-008415 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,707 Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:14 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 1,458 | $10.13 | $14,769.54 |
DisclosureSEC source: 0001562180-23-008415 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,165 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 22:19 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,625 | $0.00 Strike: $10.13 | $0.00 |
DisclosureSEC source: 0001562180-23-008171 · primarydocument.xml · derivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,375 Underlying: Common Stock · 30,625 shares Expires 2032-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2023 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 22:19 UTC | EyePoint, Inc. EYPT · Entity 5702 | SaleCommon Stock | 30,625 | $22.00 | $673,750.00 |
DisclosureSEC source: 0001562180-23-008171 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,707 Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 22:19 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 30,625 | $10.13 | $310,231.25 |
DisclosureSEC source: 0001562180-23-008171 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 13:15 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantRestricted Stock Units · Derivative | 45,855 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005443 · primarydocument.xml · derivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,855 Underlying: Common Stock · 45,855 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning January 6, 2024. F1 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning January 6, 2024. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:07 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 4,967 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001337 · primarydocument.xml · derivative · entry 6 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,967 Underlying: Common Stock · 4,967 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. F3 · derivative.expiration_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:07 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 5,833 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001337 · primarydocument.xml · derivative · entry 5 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,667 Underlying: Common Stock · 5,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2023. F2 · derivative.expiration_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2023. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:07 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 1,722 | $4.17 | $7,180.74 |
DisclosureSEC source: 0001562180-23-001337 · primarydocument.xml · nonDerivative · entry 4 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,707 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of their withholding right following the vesting of the restricted stock units. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:07 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 2,022 | $4.17 | $8,431.74 |
DisclosureSEC source: 0001562180-23-001337 · primarydocument.xml · nonDerivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,429 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of their withholding right following the vesting of the restricted stock units. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:07 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 5,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001337 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:07 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 4,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001337 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 22:50 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (Right to Buy) · Derivative | 91,655 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001562180-23-000342 · primarydocument.xml · derivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,655 Underlying: Common Stock · 91,655 shares Expires 2033-01-05 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at January 6th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 23:21 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 4,105 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002136 · primarydocument.xml · derivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,105 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vested in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. F2 · derivative.expiration_date: The restricted stock units vested in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 23:21 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 1,294 | $9.95 | $12,875.30 |
DisclosureSEC source: 0001562180-22-002136 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,651 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 23:21 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 4,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002136 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:39 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $10.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001413 · primarydocument.xml · derivative · entry 5 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2032-02-09 F4 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2023 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:39 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 4,966 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001413 · primarydocument.xml · derivative · entry 4 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,934 Underlying: Common Stock · 4,966 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. F3 · derivative.expiration_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:39 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantRestricted Stock Units · Derivative | 17,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001413 · primarydocument.xml · derivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. F2 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:39 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 1,721 | $10.13 | $17,433.73 |
DisclosureSEC source: 0001562180-22-001413 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,840 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:39 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 4,966 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001413 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,561 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 21:28 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (Right to Buy) · Derivative | 60,300 | $0.00 Strike: $13.13 | $0.00 |
DisclosureSEC source: 0001562180-21-004454 · primarydocument.xml · derivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,300 Underlying: Common Stock · 60,300 shares Expires 2031-02-09 F2 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2022 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 21:28 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantRestricted Stock Units · Derivative | 14,900 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004454 · primarydocument.xml · derivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,900 Underlying: Common Stock · 14,900 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. F1 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 21:04 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 1,420 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004274 · primarydocument.xml · derivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,420 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vests in three annual installments beginning on 14-Jun-2019 F2 · derivative.expiration_date: Vests in three annual installments beginning on 14-Jun-2019 Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 21:04 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 417 | $9.72 | $4,053.24 |
DisclosureSEC source: 0001562180-21-004274 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,595 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 21:04 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 1,420 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004274 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2021 Filed Mar 3, 2021 00:26 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 4,105 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001820 · primarydocument.xml · derivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,105 Underlying: Common Stock · 4,105 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. F2 · derivative.expiration_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. Read SEC document |
| February 28, 2021 Filed Mar 3, 2021 00:26 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 1,423 | $10.81 | $15,382.63 |
DisclosureSEC source: 0001562180-21-001820 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,592 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| February 28, 2021 Filed Mar 3, 2021 00:26 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 4,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001820 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 22:14 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 41,050 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004869 · primarydocument.xml · derivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,100 Underlying: Common Stock · 41,050 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. F2 · derivative.expiration_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 22:14 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 12,049 | $0.76 | $9,121.09 |
DisclosureSEC source: 0001562180-20-004869 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,144 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 22:14 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 41,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004869 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,193 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 27, 2020 Filed Jun 30, 2020 23:52 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004723 · primarydocument.xml · derivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On June 27, 2017, the reporting person was granted 30,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On June 27, 2017, the reporting person was granted 30,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 27, 2020 Filed Jun 30, 2020 23:52 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 2,936 | $0.79 | $2,316.50 |
DisclosureSEC source: 0001562180-20-004723 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,143 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| June 27, 2020 Filed Jun 30, 2020 23:52 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004723 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2020 Filed Jun 16, 2020 21:00 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 14,200 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004516 · primarydocument.xml · derivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,200 Underlying: Common Stock · 14,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On June 14, 2018, the reporting person was granted 42,600 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On June 14, 2018, the reporting person was granted 42,600 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 14, 2020 Filed Jun 16, 2020 21:00 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 4,168 | $0.83 | $3,441.10 |
DisclosureSEC source: 0001562180-20-004516 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,079 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| June 14, 2020 Filed Jun 16, 2020 21:00 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 14,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004516 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 23:01 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (Right to Buy) · Derivative | 246,250 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001562180-20-002042 · primarydocument.xml · derivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,250 Underlying: Common Stock · 246,250 shares Expires 2030-02-28 F2 · derivative.exercise_date: The option to purchase vests and becomes exercisable ratably in forty-eight monthly installments which began March 28, 2020 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 23:01 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantRestricted Stock Units · Derivative | 123,150 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-002042 · primarydocument.xml · derivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,150 Underlying: Common Stock · 123,150 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. F1 · derivative.expiration_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. Read SEC document |
| October 12, 2019 Filed Oct 15, 2019 22:03 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 2,450 | $2.11 | $5,157.25 |
DisclosureSEC source: 0001562180-19-005159 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,047 F1 · shares: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units F2 · price: Reflects the last reported sale price for the Registrant's shares of common stock on the Nasdaq Global Market on October 11, 2019 Read SEC document |
| June 27, 2019 Filed Jun 28, 2019 21:04 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-003676 · primarydocument.xml · derivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On June 27, 2017, the reporting person was granted 30,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On June 27, 2017, the reporting person was granted 30,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 27, 2019 Filed Jun 28, 2019 21:04 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 2,940 | $1.65 | $4,851.00 |
DisclosureSEC source: 0001562180-19-003676 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,497 F2 · shares: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| June 27, 2019 Filed Jun 28, 2019 21:04 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-003676 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 20:48 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (Right to Buy) · Derivative | 370,000 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001562180-19-003660 · primarydocument.xml · derivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,000 Underlying: Common Stock · 370,000 shares Expires 2029-02-21 F1 · derivative.exercise_date: The option to purchase vests and becomes exercisable ratably in forty-eight monthly installments which began March 21, 2019 Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 21:40 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 14,200 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-003560 · primarydocument.xml · derivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,400 Underlying: Common Stock · 14,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On June 14, 2018, the reporting person was granted 42,600 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On June 14, 2018, the reporting person was granted 42,600 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 21:40 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 4,175 | $1.53 | $6,387.75 |
DisclosureSEC source: 0001562180-19-003560 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,437 F2 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 21:40 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 14,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-003560 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,612 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 21:24 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 1,188 | $2.47 | $2,934.36 |
DisclosureSEC source: 0001562180-19-002007 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,412 F1 · shares: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units F2 · price: Reflects the last reported sale price for the Registrant's shares of common stock on the Nasdaq Global Market on March 19, 2019 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.